75
Participants
Start Date
February 20, 2025
Primary Completion Date
August 1, 2025
Study Completion Date
August 1, 2025
Intrathecal Dexmedetomidine
Patients will receive 15mg in 3ml hyperbaric bupivacaine intrathecally with 5 μg in 0.5ml dexmedetomidine + adductor canal block using 20 ml saline 0.9% at the end of surgery
Adductor Canal Block
Patients will receive 15mg in 3ml hyperbaric bupivacaine intrathecally with 0.5ml saline 0.9% + adductor canal block using 20 ml bupivacaine 0.25% at the end of surgery.
Intrathecal Dexmedetomidine + Adductor Canal Block
Patients will receive 15mg in 3ml hyperbaric bupivacaine intrathecally with 5 μg in 0.5ml dexmedetomidine + adductor canal block using 20 ml bupivacaine 0.25% at the end of surgery.
RECRUITING
Kafrelsheikh University, Kafr ash Shaykh
Kafrelsheikh University
OTHER